TABLE 1.
Characteristics of tested strains
Strain | Origin | Resistance | agr type/CCa | Associated resistances | VAN MIC (mg/liter) | Growth on BHI agar with 4 mg/liter VAN | AUC/Mu3 AUC (%) |
---|---|---|---|---|---|---|---|
FOU | Isolated from patient with cystic fibrosis | MRSA, mecA positive | II/CC5 | Kanamycin, tobramycin, erythromycin, lincomycin, fusidic acid, rifampin | 1.5 | No | 51 |
NAR | Isolated from patient with cystic fibrosis | MRSA, mecA positive | I/CC8 | Kanamycin, tobramycin, levofloxacin | 1.5 | No | 41 |
GUA | Isolated from patient with cystic fibrosis | MRSA, mecA positive | II/CC5 | Kanamycin, tobramycin, fusidic acid | 2 | No | 58 |
CC, clonal complex, determined from DNA microarray.